Blueprint Medicines, a Sanofi company, today announced AYVAKIT® (avapritinib) data showing clinically meaningful outcomes and a well-tolerated long-term safety profile in patients with indolent ...
A London woman says she was repeatedly dismissed by doctors for more than a decade before private tests finally gave her a ...
PULLING up to an empty car park in the dead of night, Brian* winds down his window. From the car next to him, another school ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results